Report - Yaning Wang - PmdaOTS/CDER/OMTP/FDA 3 Application Overview • Dose optimization – General population – Subgroups – Post-approval (PMR/PMC) • Efficacy – Supportive evidence

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form